Fluorine-18 and Radiometal Labeling of Biomolecules via Disulfide Rebridging
Bioconjugate Chemistry · 2023
DOI: 10.1021/acs.bioconjchem.3c00440 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioconjugate Chemistry, 2023. Verfasst von Mylène Richard und 6 weiteren Autor:innen. Beteiligte Einrichtung: CEA, CNRS, Inserm, BioMaps, SHFJ, Paris-Saclay University, Orsay 91401, France. Hauptthemen laut MEDLINE: Copper Radioisotopes, Fluorine Radioisotopes, Radioisotopes, Zirconium. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: Agence Nationale de la Recherche.
Abstract (Originalsprache)
Biomolecules labeled with positron-emitting radionuclides like fluorine-18 or radiometals like copper-64 and zirconium-89 are increasingly employed in nuclear medicine for diagnosis purposes. Given the fragility and complexity of these compounds, their labeling requires mild conditions. Besides, it is essential to develop methods inducing minimal modification of the tertiary structure, as it is fundamental for the biological activity of such complex entities. Given these requirements, disulfide rebridging represents a promising possibility since it allows protein modification as well as conservation of the tertiary structure. In this context, we have developed an original radiofluorinated dibromopyridazine dione prosthetic group for labeling of disulfide-containing biomolecules via rebridging. We employed it to radiolabel octreotide, a somatostatin analogue, and to radiolabel fragment antigen binding (Fab) targeting programmed death-ligand 1 (PD-L1), whose properties were then evaluated in vitro and in vivo by positron emission tomography (PET) imaging. We next extended our strategy to the radiolabeling of cetuximab, a monoclonal antibody, with various radiometals commonly used in PET imaging (zirconium-89, copper-64) by developing various rebridging molecules bearing the appropriate chelators. The stabilities of the radiolabeled antibody conjugates were assessed in biological conditions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- CEA, CNRS, Inserm, BioMaps, SHFJ, Paris-Saclay University, Orsay 91401, France.
- CEA, INRAE, Medicines and Healthcare Technologies Department, SIMoS, Paris-Saclay University, Gif-sur-Yvette 91191, France.
ORCID-Profile: Mylène Richard, Charles Truillet, Bertrand Kuhnast
Förderung
- Agence Nationale de la Recherche
Zitieren
APA
Richard, M., Martin Aubert, S., Denis, C., Dubois, S., Nozach, H., Truillet, C., & Kuhnast, B. (2023). Fluorine-18 and Radiometal Labeling of Biomolecules via Disulfide Rebridging. Bioconjugate Chemistry. https://doi.org/10.1021/acs.bioconjchem.3c00440
Vancouver
Richard M, Martin Aubert S, Denis C, Dubois S, Nozach H, Truillet C, et al. Fluorine-18 and Radiometal Labeling of Biomolecules via Disulfide Rebridging. Bioconjugate Chemistry. 2023. doi:10.1021/acs.bioconjchem.3c00440
BibTeX
@article{Richard2023,
author = {Richard, Mylène and Martin Aubert, Soizic and Denis, Caroline and Dubois, Steven and Nozach, Hervé and Truillet, Charles and Kuhnast, Bertrand},
title = {Fluorine-18 and Radiometal Labeling of Biomolecules via Disulfide Rebridging},
journal = {Bioconjugate Chemistry},
year = {2023},
doi = {10.1021/acs.bioconjchem.3c00440}
}
EUVIMED